Niclosamide for Covid-19: bridging the gap

{ 'indexed': {'date-parts': [[2024, 8, 27]], 'date-time': '2024-08-27T18:27:28Z', 'timestamp': 1724783248541}, 'reference-count': 77, 'publisher': 'Springer Science and Business Media LLC', 'issue': '12', 'license': [ { 'start': { 'date-parts': [[2021, 10, 18]], 'date-time': '2021-10-18T00:00:00Z', 'timestamp': 1634515200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}, { 'start': { 'date-parts': [[2021, 10, 18]], 'date-time': '2021-10-18T00:00:00Z', 'timestamp': 1634515200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 12]]}, 'DOI': '10.1007/s11033-021-06770-7', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 10, 19]], 'date-time': '2021-10-19T02:51:21Z', 'timestamp': 1634611881000}, 'page': '8195-8202', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 49, 'title': 'Niclosamide for Covid-19: bridging the gap', 'prefix': '10.1007', 'volume': '48', 'author': [ {'given': 'Hayder M.', 'family': 'Al-kuraishy', 'sequence': 'first', 'affiliation': []}, {'given': 'Ali I.', 'family': 'Al-Gareeb', 'sequence': 'additional', 'affiliation': []}, {'given': 'Khalid J.', 'family': 'Alzahrani', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-2206-7236', 'authenticated-orcid': False, 'given': 'Athanasios', 'family': 'Alexiou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gaber El-Saber', 'family': 'Batiha', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 10, 18]]}, 'reference': [ { 'key': '6770_CR1', 'doi-asserted-by': 'publisher', 'first-page': '114431', 'DOI': '10.1016/j.bcp.2021.114431', 'volume': '185', 'author': 'C Lugnier', 'year': '2021', 'unstructured': 'Lugnier C, Al-Kuraishy HM, Rousseau E (2021) PDE4 inhibition as a ' 'therapeutic strategy for improvement of pulmonary dysfunctions in ' 'Covid-19 and cigarette smoking. Biochem Pharmacol 185:114431', 'journal-title': 'Biochem Pharmacol'}, { 'key': '6770_CR2', 'first-page': '71', 'volume': '8', 'author': 'HM Al-Kuraishy', 'year': '2021', 'unstructured': 'Al-Kuraishy HM, Al-Gareeb AI, Cruz-Martins N, Batiha GE (2021) ' 'Hyperbilirubinemia in Gilbert syndrome attenuates Covid-19 ' 'induced-metabolic disturbances: a case-report study. Front Cardiovasc ' 'Med 8:71', 'journal-title': 'Front Cardiovasc Med'}, { 'issue': '4', 'key': '6770_CR3', 'doi-asserted-by': 'publisher', 'first-page': '141', 'DOI': '10.4103/JMAU.JMAU_63_20', 'volume': '8', 'author': 'HM Al-Kuraishy', 'year': '2020', 'unstructured': 'Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Al-Buhadily AK, Al-Harchan ' 'NA, Lugnier C (2020) COVID-19 and phosphodiesterase enzyme type 5 ' 'inhibitors. J Microsc Ultrastructure 8(4):141', 'journal-title': 'J Microsc Ultrastructure'}, { 'issue': '3', 'key': '6770_CR4', 'doi-asserted-by': 'publisher', 'first-page': '189', 'DOI': '10.4103/bbrj.bbrj_103_20', 'volume': '4', 'author': 'HM Al-Kuraishy', 'year': '2020', 'unstructured': 'Al-Kuraishy HM, Al-Naimi MS, Lungnier CM, Al-Gareeb AI (2020) Macrolides ' 'and COVID-19: an optimum premise. Biomed Biotechnol Res J 4(3):189', 'journal-title': 'Biomed Biotechnol Res J'}, { 'issue': '5', 'key': '6770_CR5', 'doi-asserted-by': 'crossref', 'first-page': '33', 'DOI': '10.4103/bbrj.bbrj_105_20', 'volume': '4', 'author': 'HM Al-Kuraishy', 'year': '2020', 'unstructured': 'Al-Kuraishy HM, Hussien NR, Al-Naimi MS, Al-Buhadily AK, Al-Gareeb AI, ' 'Lungnier C (2020) Renin-Angiotensin system and fibrinolytic pathway in ' 'COVID-19: One-way skepticism. Biomed Biotechnol Res J 4(5):33', 'journal-title': 'Biomed Biotechnol Res J'}, { 'issue': '1', 'key': '6770_CR6', 'doi-asserted-by': 'publisher', 'first-page': '33', 'DOI': '10.1038/s43588-020-00007-6', 'volume': '1', 'author': 'G Galindez', 'year': '2021', 'unstructured': 'Galindez G, Matschinske J, Rose TD, Sadegh S, Salgado-Albarrán M, Späth ' 'J, Baumbach J, Pauling JK (2021) Lessons from the COVID-19 pandemic for ' 'advancing computational drug repurposing strategies. Nat Comput Sci ' '1(1):33–41', 'journal-title': 'Nat Comput Sci'}, { 'issue': '2', 'key': '6770_CR7', 'doi-asserted-by': 'publisher', 'first-page': '339', 'DOI': '10.1007/s40519-017-0373-1', 'volume': '22', 'author': 'AI Al-Gareeb', 'year': '2017', 'unstructured': 'Al-Gareeb AI, Aljubory KD, Alkuraishy HM (2017) Niclosamide as an ' 'anti-obesity drug: an experimental study. Eating and Weight ' 'Disorders-Studies on Anorexia, Bulimia and Obesity 22(2):339–344', 'journal-title': 'Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity'}, { 'issue': '2', 'key': '6770_CR8', 'doi-asserted-by': 'publisher', 'first-page': '245', 'DOI': '10.1016/0163-7258(82)90064-X', 'volume': '19', 'author': 'P Andrews', 'year': '1982', 'unstructured': 'Andrews P, Thyssen J, Lorke D (1982) The biology and toxicology of ' 'molluscicides. Bayluscide Pharmacol Ther 19(2):245–295', 'journal-title': 'Bayluscide Pharmacol Ther'}, { 'key': '6770_CR9', 'unstructured': 'World Health Organization (2009) The selection and use of essential ' 'medicines: report of the WHO Expert Committee, March 2009 (including the ' '16th WHO model list of essential medicines and the 2nd WHO model list of ' 'essential medicines for children). World Health Organization, Geneva'}, { 'key': '6770_CR10', 'doi-asserted-by': 'publisher', 'first-page': '89', 'DOI': '10.1016/j.cellsig.2017.04.001', 'volume': '41', 'author': 'W Chen', 'year': '2018', 'unstructured': 'Chen W, Mook RA Jr, Premont RT, Wang J (2018) Niclosamide: beyond an ' 'antihelminthic drug. Cell Signal 41:89–96', 'journal-title': 'Cell Signal'}, { 'issue': '1', 'key': '6770_CR11', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1006/pest.1995.1049', 'volume': '53', 'author': 'OM AwAD', 'year': '1995', 'unstructured': 'AwAD OM (1995) Assessment of the developmental toxicity of in utero ' 'exposure of Wistar albino rats to ametryne and Niclosamide. Pestic ' 'Biochem Physiol 53(1):1–9', 'journal-title': 'Pestic Biochem Physiol'}, { 'issue': '10', 'key': '6770_CR12', 'doi-asserted-by': 'publisher', 'first-page': 'e1002976', 'DOI': '10.1371/journal.ppat.1002976', 'volume': '8', 'author': 'A Jurgeit', 'year': '2012', 'unstructured': 'Jurgeit A, McDowell R, Moese S, Meldrum E, Schwendener R, Greber UF ' '(2012) Niclosamide is a proton carrier and targets acidic endosomes with ' 'broad antiviral effects. PLoS Pathog 8(10):e1002976', 'journal-title': 'PLoS Pathog'}, { 'key': '6770_CR13', 'doi-asserted-by': 'publisher', 'first-page': '81', 'DOI': '10.1016/j.antiviral.2016.10.003', 'volume': '135', 'author': 'YM Wang', 'year': '2016', 'unstructured': 'Wang YM, Lu JW, Lin CC, Chin YF, Wu TY, Lin LI, Lai ZZ, Kuo SC, Ho YJ ' '(2016) Antiviral activities of Niclosamide and nitazoxanide against ' 'chikungunya virus entry and transmission. Antiviral Res 135:81–90', 'journal-title': 'Antiviral Res'}, { 'key': '6770_CR14', 'doi-asserted-by': 'publisher', 'first-page': '1101', 'DOI': '10.1038/nm.4184', 'volume': '22', 'author': 'M Xu', 'year': '2016', 'unstructured': 'Xu M, Lee EM, Wen Z, Cheng Y, Huang WK, Qian X et al (2016) ' 'Identification of small-molecule inhibitors of Zika virus infection and ' 'induced neural cell death via a drug repurposing screen. Nat Med ' '22:1101–1107', 'journal-title': 'Nat Med'}, { 'key': '6770_CR15', 'doi-asserted-by': 'publisher', 'first-page': '68', 'DOI': '10.1016/j.antiviral.2016.12.002', 'volume': '138', 'author': 'L Huang', 'year': '2017', 'unstructured': 'Huang L, Yang M, Yuan Y, Li X, Kuang E (2017) Niclosamide inhibits lytic ' 'replication of Epstein-Barr virus by disrupting mTOR activation. ' 'Antiviral Res 138:68–78', 'journal-title': 'Antiviral Res'}, { 'issue': '8', 'key': '6770_CR16', 'doi-asserted-by': 'publisher', 'first-page': '6715', 'DOI': '10.1371/journal.pntd.0006715', 'volume': '12', 'author': 'JC Kao', 'year': '2018', 'unstructured': 'Kao JC, HuangFu WC, Tsai TT, Ho MR, Jhan MK, Shen TJ, Tseng PC, Wang YT, ' 'Lin CF (2018) The antiparasitic drug niclosamide inhibits dengue virus ' 'infection by interfering with endosomal acidification independent of ' 'mTOR. PLoS Negl Trop Dis 12(8):6715', 'journal-title': 'PLoS Negl Trop Dis'}, { 'issue': '11', 'key': '6770_CR17', 'doi-asserted-by': 'publisher', 'first-page': '4069', 'DOI': '10.1128/AAC.00078-08', 'volume': '52', 'author': 'BE Korba', 'year': '2008', 'unstructured': 'Korba BE, Elazar M, Lui P, Rossignol JF, Glenn JS (2008) Potential for ' 'hepatitis C virus resistance to nitazoxanide or tizoxanide. Antimicrob ' 'Agents Chemother 52(11):4069–4071', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '7', 'key': '6770_CR18', 'doi-asserted-by': 'publisher', 'first-page': '317', 'DOI': '10.1021/acsinfecdis.5b00030', 'volume': '1', 'author': 'PB Madrid', 'year': '2015', 'unstructured': 'Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, ' 'Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S (2015) ' 'Evaluation of Ebola virus inhibitors for drug repurposing. ACS Infect ' 'Dis 1(7):317–326', 'journal-title': 'ACS Infect Dis'}, { 'issue': '1', 'key': '6770_CR19', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1038/s41598-018-37290-3', 'volume': '9', 'author': 'JA Marrugal-Lorenzo', 'year': '2019', 'unstructured': 'Marrugal-Lorenzo JA, Serna-Gallego A, Berastegui-Cabrera J, Pachón J, ' 'Sánchez-Céspedes J (2019) Repositioning salicylanilide anthelmintic ' 'drugs to treat adenovirus infections. Sci Rep 9(1):1', 'journal-title': 'Sci Rep'}, { 'issue': '8', 'key': '6770_CR20', 'doi-asserted-by': 'publisher', 'first-page': '734', 'DOI': '10.3390/life11080734', 'volume': '11', 'author': 'M Moubarak', 'year': '2021', 'unstructured': 'Moubarak M, Kasozi KI, Hetta HF, Shaheen HM, Rauf A, Al-kuraishy HM et ' 'al (2021) The rise of SARS-CoV-2 variants and the role of convalescent ' 'plasma therapy for management of infections. Life 11(8):734', 'journal-title': 'Life'}, { 'key': '6770_CR21', 'doi-asserted-by': 'publisher', 'first-page': '644095', 'DOI': '10.3389/fcvm.2021.644095', 'volume': '8', 'author': 'HM Al-Kuraishy', 'year': '2021', 'unstructured': 'Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, ' 'Batiha GE (2021) COVID-19 in relation to hyperglycemia and diabetes ' 'mellitus. Front Cardiovasc Med 8:644095', 'journal-title': 'Front Cardiovasc Med'}, { 'issue': '4', 'key': '6770_CR22', 'doi-asserted-by': 'publisher', 'first-page': '234', 'DOI': '10.1016/j.ajic.2005.12.006', 'volume': '34', 'author': 'J Yuan', 'year': '2006', 'unstructured': 'Yuan J, Yun H, Lan W, Wang W, Sullivan SG, Jia S, Bittles AH (2006) A ' 'climatologic investigation of the SARS-CoV outbreak in Beijing, China. ' 'Am J Infect Control 34(4):234–236', 'journal-title': 'Am J Infect Control'}, { 'issue': '4', 'key': '6770_CR23', 'doi-asserted-by': 'publisher', 'first-page': '891', 'DOI': '10.1016/j.idc.2019.08.001', 'volume': '33', 'author': 'EI Azhar', 'year': '2019', 'unstructured': 'Azhar EI, Hui DS, Memish ZA, Drosten C, Zumla A (2019) The middle east ' 'respiratory syndrome (MERS). Infect Dis Clin 33(4):891–905', 'journal-title': 'Infect Dis Clin'}, { 'issue': '7', 'key': '6770_CR24', 'doi-asserted-by': 'publisher', 'first-page': '2693', 'DOI': '10.1128/AAC.48.7.2693-2696.2004', 'volume': '48', 'author': 'CJ Wu', 'year': '2004', 'unstructured': 'Wu CJ, Jan JT, Chen CM, Hsieh HP, Hwang DR, Liu HW, Liu CY, Huang HW, ' 'Chen SC, Hong CF, Lin RK (2004) Inhibition of severe acute respiratory ' 'syndrome coronavirus replication by Niclosamide. Antimicrob Agents ' 'Chemother 48(7):2693–2696', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '13', 'key': '6770_CR25', 'doi-asserted-by': 'publisher', 'first-page': '4469', 'DOI': '10.1021/jm050184y', 'volume': '48', 'author': 'JJ Shie', 'year': '2005', 'unstructured': 'Shie JJ, Fang JM, Kuo CJ, Kuo TH, Liang PH, Huang HJ, Yang WB, Lin CH, ' 'Chen JL, Wu YT, Wong CH (2005) Discovery of potent anilide inhibitors ' 'against the severe acute respiratory syndrome 3CL protease. J Med Chem ' '48(13):4469–4473', 'journal-title': 'J Med Chem'}, { 'issue': '1', 'key': '6770_CR26', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1038/s41467-019-13659-4', 'volume': '10', 'author': 'NC Gassen', 'year': '2019', 'unstructured': 'Gassen NC, Niemeyer D, Muth D, Corman VM, Martinelli S, Gassen A, Hafner ' 'K, Papies J, Mösbauer K, Zellner A, Zannas AS (2019) SKP2 attenuates ' 'autophagy through Beclin1-ubiquitination and its inhibition reduces ' 'MERS-Coronavirus infection. Nat Commun 10(1):1–6', 'journal-title': 'Nat Commun'}, { 'key': '6770_CR27', 'doi-asserted-by': 'publisher', 'first-page': '102008', 'DOI': '10.1016/j.pupt.2021.102008', 'volume': '67', 'author': 'HM Al-Kuraishy', 'year': '2021', 'unstructured': 'Al-Kuraishy HM, Al-Gareeb AI, Qusty N, Cruz-Martins N, Batiha GE (2021) ' 'Sequential doxycycline and colchicine combination therapy in Covid-19: ' 'The salutary effects. Pulmonary Pharmacol Ther. 67:102008', 'journal-title': 'Pulmonary Pharmacol Ther.'}, { 'key': '6770_CR28', 'doi-asserted-by': 'publisher', 'first-page': '7295', 'DOI': '10.33263/BRIAC106.72957328', 'volume': '10', 'author': 'D Romani', 'year': '2020', 'unstructured': 'Romani D, Noureddine O, Issaoui N, Brandán SA (2020) Properties and ' 'reactivities of Niclosamide in different media, a potential antiviral to ' 'treatment of COVID-19 by using DFT calculations and molecular docking. ' 'Biointerface Res Appl Chem 10:7295–7328', 'journal-title': 'Biointerface Res Appl Chem'}, { 'key': '6770_CR29', 'doi-asserted-by': 'crossref', 'unstructured': 'Guthappa R (2020) Molecular docking studies of N-acetyl cysteine, zinc ' 'acetyl cysteine and niclosamide on SARS Cov 2 protease and its ' 'comparison with hydroxychloroquine. Chemarxiv', 'DOI': '10.26434/chemrxiv.12161493'}, { 'issue': '5', 'key': '6770_CR30', 'doi-asserted-by': 'publisher', 'first-page': '909', 'DOI': '10.1021/acsinfecdis.0c00052', 'volume': '6', 'author': 'J Xu', 'year': '2020', 'unstructured': 'Xu J, Shi PY, Li H, Zhou J (2020) Broad spectrum antiviral agent ' 'niclosamide and its therapeutic potential. ACS Infect Dis 6(5):909–915', 'journal-title': 'ACS Infect Dis'}, { 'issue': '7', 'key': '6770_CR31', 'doi-asserted-by': 'publisher', 'first-page': 'e00819', 'DOI': '10.1128/AAC.00819-20', 'volume': '64', 'author': 'S Jeon', 'year': '2020', 'unstructured': 'Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, Shum D, Kim S (2020) ' 'Identification of antiviral drug candidates against SARS-CoV-2 from ' 'FDA-approved drugs. Antimicrob Agents Chemother 64(7):e00819-e820', 'journal-title': 'Antimicrob Agents Chemother'}, { 'issue': '2', 'key': '6770_CR32', 'doi-asserted-by': 'publisher', 'first-page': 'e0246803', 'DOI': '10.1371/journal.pone.0246803', 'volume': '16', 'author': 'AD Brunaugh', 'year': '2021', 'unstructured': 'Brunaugh AD, Seo H, Warnken Z, Ding L, Seo SH, Smyth HD (2021) ' 'Development and evaluation of inhalable composite niclosamide-lysozyme ' 'particles: A broad-spectrum, patient-adaptable treatment for coronavirus ' 'infections and sequalae. PLoS ONE 16(2):e0246803', 'journal-title': 'PLoS ONE'}, { 'issue': '1', 'key': '6770_CR33', 'doi-asserted-by': 'publisher', 'first-page': '724', 'DOI': '10.33218/001c.18813', 'volume': '4', 'author': 'G Wang', 'year': '2021', 'unstructured': 'Wang G, Gaikwad H, McCarthy M, Gonzalez-Juarrero M, Li Y, Armstrong M, ' 'Reisdorph N, Morrison T, Simberg D (2021) Lipid nanoparticle formulation ' 'of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in ' 'vitro. Precis Nanomed 4(1):724–737', 'journal-title': 'Precis Nanomed'}, { 'key': '6770_CR34', 'doi-asserted-by': 'crossref', 'unstructured': 'Jara MO, Warnken ZN, Sahakijpijarn S, Moon C, Maier EY, Christensen DJ, ' 'Koleng JJ, Peters JI, Hackman SD, Williams RO (2021) Niclosamide ' 'Inhalation powder made by thin-film freezing: pharmacokinetic and ' 'toxicology studies in rats and hamsters. bioRxiv', 'DOI': '10.1101/2021.01.26.428293'}, { 'issue': '3', 'key': '6770_CR35', 'doi-asserted-by': 'publisher', 'first-page': '225', 'DOI': '10.1007/s00011-015-0801-5', 'volume': '64', 'author': 'L Liang', 'year': '2015', 'unstructured': 'Liang L, Huang M, Xiao Y, Zen S, Lao M, Zou Y, Shi M, Yang X, Xu H ' '(2015) Inhibitory effects of Niclosamide on inflammation and migration ' 'of fibroblast-like synoviocytes from patients with rheumatoid arthritis. ' 'Inflamm Res 64(3):225–233', 'journal-title': 'Inflamm Res'}, { 'issue': '15', 'key': '6770_CR36', 'doi-asserted-by': 'publisher', 'first-page': 'e128414', 'DOI': '10.1172/jci.insight.128414', 'volume': '4', 'author': 'I Cabrita', 'year': '2019', 'unstructured': 'Cabrita I, Benedetto R, Schreiber R, Kunzelmann K (2019) Niclosamide ' 'repurposed for the treatment of inflammatory airway disease. JCI Insight ' '4(15):e128414', 'journal-title': 'JCI Insight'}, { 'key': '6770_CR37', 'doi-asserted-by': 'crossref', 'unstructured': 'Costabile G, d’Angelo I, Rampioni G, Bondì R, Pompili B, Ascenzioni F, ' 'Mitidieri E, d’Emmanuele di Villa Bianca R, Sorrentino R, Miro A, ' 'Quaglia F (2015) Toward repositioning Niclosamide for antivirulence ' 'therapy of Pseudomonas aeruginosa lung infections: development of ' 'inhalable formulations through nanosuspension technology. Mol Pharm ' '12(8):2604–2617', 'DOI': '10.1021/acs.molpharmaceut.5b00098'}, { 'issue': '2', 'key': '6770_CR38', 'doi-asserted-by': 'publisher', 'first-page': '1810', 'DOI': '10.3892/mmr.2017.6768', 'volume': '16', 'author': 'LX Zhang', 'year': '2017', 'unstructured': 'Zhang LX, Zhao HJ, Sun DL, Gao SL, Zhang HM, Ding XG (2017) Niclosamide ' 'attenuates inflammatory cytokines via the autophagy pathway leading to ' 'improved outcomes in renal ischemia/reperfusion injury. Mol Med Rep ' '16(2):1810–1816', 'journal-title': 'Mol Med Rep'}, { 'issue': '1', 'key': '6770_CR39', 'doi-asserted-by': 'publisher', 'first-page': '250', 'DOI': '10.1002/jmv.26232', 'volume': '93', 'author': 'B Hu', 'year': '2021', 'unstructured': 'Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol ' '93(1):250–256', 'journal-title': 'J Med Virol'}, { 'issue': '24', 'key': '6770_CR40', 'doi-asserted-by': 'publisher', 'first-page': '10284', 'DOI': '10.1021/acs.jpclett.0c02677', 'volume': '11', 'author': 'A Mehranfar', 'year': '2020', 'unstructured': 'Mehranfar A, Izadyar M (2020) Theoretical design of functionalized gold ' 'nanoparticles as antiviral agents against Severe Acute Respiratory ' 'Syndrome Coronavirus 2 (SARS-CoV-2). J Phys Chem Lett 11(24):10284–10289', 'journal-title': 'J Phys Chem Lett'}, { 'key': '6770_CR41', 'doi-asserted-by': 'publisher', 'first-page': '173438', 'DOI': '10.1016/j.ejphar.2020.173438', 'volume': '887', 'author': 'CL Braga', 'year': '2020', 'unstructured': 'Braga CL, Felix NS, Teixeira DE, Vieira JB, Silva-Aguiar RP, Bose RM, ' 'Antunes MA, de Novaes Rocha N, Caruso-Neves C, Cruz FF, Rocco PR (2020) ' 'Niclosamide attenuates lung vascular remodeling in experimental ' 'pulmonary arterial hypertension. Eur J Pharmacol 887:173438', 'journal-title': 'Eur J Pharmacol'}, { 'issue': '17', 'key': '6770_CR42', 'doi-asserted-by': 'publisher', 'first-page': '1324', 'DOI': '10.1136/heartjnl-2020-317355', 'volume': '106', 'author': 'M Pagnesi', 'year': '2020', 'unstructured': 'Pagnesi M, Baldetti L, Beneduce A, Calvo F, Gramegna M, Pazzanese V, ' 'Ingallina G, Napolano A, Finazzi R, Ruggeri A, Ajello S (2020) Pulmonary ' 'hypertension and right ventricular involvement in hospitalised patients ' 'with COVID-19. Heart 106(17):1324–1331', 'journal-title': 'Heart'}, { 'key': '6770_CR43', 'doi-asserted-by': 'publisher', 'first-page': '649128', 'DOI': '10.3389/fnut.2021.649128', 'volume': '8', 'author': 'HM Al-Kuraishy', 'year': '2021', 'unstructured': 'Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, ' 'Batiha GE (2021) The looming effects of estrogen in Covid-19: a rocky ' 'rollout. Front Nutr 8:649128', 'journal-title': 'Front Nutr'}, { 'issue': '1', 'key': '6770_CR44', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1038/s41598-020-80010-z', 'volume': '11', 'author': 'Y Zuo', 'year': '2021', 'unstructured': 'Zuo Y, Warnock M, Harbaugh A, Yalavarthi S, Gockman K, Zuo M, Madison ' 'JA, Knight JS, Kanthi Y, Lawrence DA (2021) Plasma tissue plasminogen ' 'activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 ' 'patients. Sci Rep 11(1):1–9', 'journal-title': 'Sci Rep'}, { 'issue': '36', 'key': '6770_CR45', 'doi-asserted-by': 'publisher', 'first-page': '22351', 'DOI': '10.1073/pnas.2010229117', 'volume': '117', 'author': 'S Kang', 'year': '2020', 'unstructured': 'Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, Matsumoto H, ' 'Matsuura H, Matsubara T, Shimizu K, Ogura H (2020) IL-6 trans-signaling ' 'induces plasminogen activator inhibitor-1 from vascular endothelial ' 'cells in cytokine release syndrome. Proc Natl Acad Sci USA ' '117(36):22351–22356', 'journal-title': 'Proc Natl Acad Sci USA'}, { 'issue': '1', 'key': '6770_CR46', 'first-page': '1', 'volume': '8', 'author': 'LH Wang', 'year': '2018', 'unstructured': 'Wang LH, Xu M, Fu LQ, Chen XY, Yang F (2018) The antihelminthic ' 'Niclosamide inhibits cancer stemness, extracellular matrix remodeling, ' 'and metastasis through dysregulation of the nuclear β-catenin/c-Myc axis ' 'in OSCC. Sci Rep 8(1):1–3', 'journal-title': 'Sci Rep'}, { 'issue': '1', 'key': '6770_CR47', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1038/s41598-019-47707-2', 'volume': '9', 'author': 'J Gyamfi', 'year': '2019', 'unstructured': 'Gyamfi J, Lee YH, Min BS, Choi J (2019) Niclosamide reverses adipocyte ' 'induced epithelial-mesenchymal transition in breast cancer cells via ' 'suppression of the interleukin-6/STAT3 signalling axis. Sci Rep 9(1):1–4', 'journal-title': 'Sci Rep'}, { 'key': '6770_CR48', 'first-page': '1', 'volume': '28', 'author': 'HM Al-Kuraishy', 'year': '2021', 'unstructured': 'Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE ' '(2021) The potential role of neopterin in Covid-19: a new perspective. ' 'Mol Cell Biochem 28:1–6', 'journal-title': 'Mol Cell Biochem'}, { 'key': '6770_CR49', 'doi-asserted-by': 'crossref', 'unstructured': 'Gassen NC, Papies J, Bajaj T, Dethloff F, Emanuel J, Weckmann K, Heinz ' 'DE, Heinemann N, Lennarz M, Richter A, Niemeyer D (2020) Analysis of ' 'SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and ' 'niclosamide as putative antiviral therapeutics. BioRxiv', 'DOI': '10.1101/2020.04.15.997254'}, { 'key': '6770_CR50', 'doi-asserted-by': 'publisher', 'first-page': '104574', 'DOI': '10.1016/j.bioorg.2020.104574', 'volume': '107', 'author': 'X He', 'year': '2021', 'unstructured': 'He X, Li M, Ye W, Zhou W (2021) Discovery of degradable niclosamide ' 'derivatives able to specially inhibit small cell lung cancer (SCLC). ' 'Bioorg Chem 107:104574', 'journal-title': 'Bioorg Chem'}, { 'issue': '6', 'key': '6770_CR51', 'doi-asserted-by': 'publisher', 'first-page': '178', 'DOI': '10.3390/cancers10060178', 'volume': '10', 'author': 'R Aloni-Grinstein', 'year': '2018', 'unstructured': 'Aloni-Grinstein R, Charni-Natan M, Solomon H, Rotter V (2018) p53 and ' 'the viral connection: back into the future. Cancers 10(6):178', 'journal-title': 'Cancers'}, { 'issue': '5', 'key': '6770_CR52', 'doi-asserted-by': 'crossref', 'first-page': '101', 'DOI': '10.4103/bbrj.bbrj_109_20', 'volume': '4', 'author': 'HM Al-Kuraishy', 'year': '2020', 'unstructured': 'Al-Kuraishy HM, Hussien NR, Al-Naimi MS, Al-Buhadily AK, Al-Gareeb AI, ' 'Lungnier C (2020) Is ivermectin–azithromycin combination the next step ' 'for COVID-19? Biomed Biotechnol Res J 4(5):101', 'journal-title': 'Biomed Biotechnol Res J'}, { 'key': '6770_CR53', 'doi-asserted-by': 'publisher', 'first-page': '110', 'DOI': '10.3389/fmed.2021.644295', 'volume': '8', 'author': 'HM Al-Kuraishy', 'year': '2021', 'unstructured': 'Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Cruz-Martins N, Batiha GE ' '(2021) COVID-19 and risk of acute ischemic stroke and acute lung injury ' 'in patients with type ii diabetes mellitus: the anti-inflammatory role ' 'of metformin. Front Med 8:110', 'journal-title': 'Front Med'}, { 'key': '6770_CR54', 'first-page': '5426', 'volume': '21', 'author': 'N Hu', 'year': '2021', 'unstructured': 'Hu N, Fu Y, Li WF, Yang XR, Cao M, Li FF, Chen JH, Chen XY, Zhao H, Sun ' 'ZJ, Dong DL (2021) Chemical mitochondrial uncouplers share common ' 'inhibitory effect on NLRP3 inflammasome activation through inhibiting ' 'NFκB nuclear translocation. Toxicol Appl Pharmacol 21:5426', 'journal-title': 'Toxicol Appl Pharmacol'}, { 'issue': '3', 'key': '6770_CR55', 'doi-asserted-by': 'publisher', 'first-page': '1403', 'DOI': '10.1002/jmv.26397', 'volume': '93', 'author': 'M Ko', 'year': '2021', 'unstructured': 'Ko M, Jeon S, Ryu WS, Kim S (2021) Comparative analysis of antiviral ' 'efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. J ' 'Med Virol 93(3):1403–1408', 'journal-title': 'J Med Virol'}, { 'issue': '1', 'key': '6770_CR56', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s40064-016-3153-x', 'volume': '5', 'author': 'J Zhao', 'year': '2016', 'unstructured': 'Zhao J, He Q, Gong Z, Chen S, Cui L (2016) Niclosamide suppresses renal ' 'cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial ' 'dysfunctions. Springerplus 5(1):1–8', 'journal-title': 'Springerplus'}, { 'key': '6770_CR57', 'doi-asserted-by': 'publisher', 'first-page': '102', 'DOI': '10.1016/j.mehy.2020.110102', 'volume': '143', 'author': 'R Cecchini', 'year': '2020', 'unstructured': 'Cecchini R, Cecchini AL (2020) SARS-CoV-2 infection pathogenesis is ' 'related to oxidative stress as a response to aggression. Med Hypotheses ' '143:102', 'journal-title': 'Med Hypotheses'}, { 'issue': '8', 'key': '6770_CR58', 'doi-asserted-by': 'publisher', 'first-page': '1040', 'DOI': '10.1016/j.annonc.2020.04.479', 'volume': '31', 'author': 'M Montopoli', 'year': '2020', 'unstructured': 'Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, Carbone ' 'GM, Cavalli A, Pagano F, Ragazzi E, Prayer-Galetti T (2020) ' 'Androgen-deprivation therapies for prostate cancer and risk of infection ' 'by SARS-CoV-2: a population-based study (n= 4532). Ann Oncol ' '31(8):1040–1045', 'journal-title': 'Ann Oncol'}, { 'issue': '22', 'key': '6770_CR59', 'doi-asserted-by': 'publisher', 'first-page': '32210', 'DOI': '10.18632/oncotarget.8493', 'volume': '7', 'author': 'C Liu', 'year': '2016', 'unstructured': 'Liu C, Armstrong C, Zhu Y, Lou W, Gao AC (2016) Niclosamide enhances ' 'abiraterone treatment via inhibition of androgen receptor variants in ' 'castration resistant prostate cancer. Oncotarget 7(22):32210', 'journal-title': 'Oncotarget'}, { 'issue': '1–2', 'key': '6770_CR60', 'doi-asserted-by': 'publisher', 'first-page': '15', 'DOI': '10.1016/j.cellimm.2013.12.006', 'volume': '288', 'author': 'CS Wu', 'year': '2014', 'unstructured': 'Wu CS, Li YR, Chen JJ, Chen YC, Chu CL, Pan IH, Wu YS, Lin CC (2014) ' 'Antihelminthic Niclosamide modulates dendritic cells activation and ' 'function. Cell Immunol 288(1–2):15–23', 'journal-title': 'Cell Immunol'}, { 'issue': '5', 'key': '6770_CR61', 'doi-asserted-by': 'publisher', 'first-page': '1011', 'DOI': '10.1093/biolre/ioaa010', 'volume': '102', 'author': 'N Sekulovski', 'year': '2020', 'unstructured': 'Sekulovski N, Whorton AE, Tanaka T, Hirota Y, Shi M, MacLean JA, de Mola ' 'JR, Groesch K, Diaz-Sylvester P, Wilson T, Hayashi K (2020) Niclosamide ' 'suppresses macrophage-induced inflammation in endometriosis. Biol Reprod ' '102(5):1011–1019', 'journal-title': 'Biol Reprod'}, { 'issue': '9', 'key': '6770_CR62', 'doi-asserted-by': 'publisher', 'first-page': '1152', 'DOI': '10.1136/annrheumdis-2020-218048', 'volume': '79', 'author': 'P Ruscitti', 'year': '2020', 'unstructured': 'Ruscitti P, Bruno F, Berardicurti O, Acanfora C, Pavlych V, Palumbo P, ' 'Conforti A, Carubbi F, Di Cola I, Di Benedetto P, Cipriani P (2020) Lung ' 'involvement in macrophage activation syndrome and severe COVID-19: ' 'results from a cross-sectional study to assess clinical, laboratory and ' 'artificial intelligence–radiological differences. Ann Rheum Dis ' '79(9):1152–1155', 'journal-title': 'Ann Rheum Dis'}, { 'key': '6770_CR63', 'doi-asserted-by': 'crossref', 'unstructured': 'Garrett T, Coatsworth H, Mahmud I, Hamerly T, Stephenson CJ, Yazd H, ' 'Ayers JB, Miller M, Lednicky JA, Dinglasan RR (2021) Niclosamide ' 'reverses SARS-CoV-2 control of lipophagy. bioRxiv', 'DOI': '10.1101/2021.07.11.451951'}, { 'issue': '7', 'key': '6770_CR64', 'doi-asserted-by': 'publisher', 'first-page': '2557', 'DOI': '10.3390/ijms21072557', 'volume': '21', 'author': 'R Centeio', 'year': '2020', 'unstructured': 'Centeio R, Cabrita I, Benedetto R, Talbi K, Ousingsawat J, Schreiber R, ' 'Sullivan JK, Kunzelmann K (2020) Pharmacological inhibition and ' 'activation of the Ca2+ activated Cl−channel TMEM16A. Int J Mol Sci ' '21(7):2557', 'journal-title': 'Int J Mol Sci'}, { 'key': '6770_CR65', 'doi-asserted-by': 'publisher', 'first-page': '51', 'DOI': '10.3389/fphar.2019.00051', 'volume': '10', 'author': 'K Miner', 'year': '2019', 'unstructured': 'Miner K, Labitzke K, Liu B, Wang P, Henckels K, Gaida K, Elliott R, Chen ' 'JJ, Liu L, Leith A, Trueblood E (2019) Drug repurposing: the ' 'anthelmintics niclosamide and nitazoxanide are potent TMEM16A ' 'antagonists that fully bronchodilate airways. Front Pharmacol 10:51', 'journal-title': 'Front Pharmacol'}, { 'issue': '8', 'key': '6770_CR66', 'doi-asserted-by': 'publisher', 'first-page': '1046', 'DOI': '10.1038/cr.2017.88', 'volume': '27', 'author': 'Z Li', 'year': '2017', 'unstructured': 'Li Z, Brecher M, Deng YQ, Zhang J, Sakamuru S, Liu B, Huang R, Koetzner ' 'CA, Allen CA, Jones SA, Chen H (2017) Existing drugs as broad-spectrum ' 'and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. ' 'Cell Res 27(8):1046–1064', 'journal-title': 'Cell Res'}, { 'key': '6770_CR67', 'doi-asserted-by': 'publisher', 'first-page': 'S28', 'DOI': '10.1016/j.tube.2019.04.008', 'volume': '116', 'author': 'X Fan', 'year': '2019', 'unstructured': 'Fan X, Xu J, Files M, Cirillo JD, Endsley JJ, Zhou J, Endsley MA (2019) ' 'Dual activity of niclosamide to suppress replication of integrated HIV-1 ' 'and Mycobacterium tuberculosis (Beijing). Tuberculosis 116:S28-33', 'journal-title': 'Tuberculosis'}, { 'key': '6770_CR68', 'doi-asserted-by': 'crossref', 'unstructured': 'Weiss A, Touret F, Baronti C, Gilles M, Hoen B, Nougairède A, de ' 'Lamballerie X, Sommer MO (2021) Niclosamide shows strong antiviral ' 'activity in a human airway model of SARS-CoV-2 infection and a conserved ' 'potency against the UK B. 1.1. 7 and SA B. 1.351 variant. bioRxiv', 'DOI': '10.1101/2021.04.26.441457'}, { 'issue': '1', 'key': '6770_CR69', 'doi-asserted-by': 'publisher', 'first-page': '145', 'DOI': '10.1080/14756366.2019.1690480', 'volume': '35', 'author': 'S Jo', 'year': '2020', 'unstructured': 'Jo S, Kim S, Shin DH, Kim MS (2020) Inhibition of SARS-CoV 3CL protease ' 'by flavonoids. J Enzyme Inhib Med Chem 35(1):145–151', 'journal-title': 'J Enzyme Inhib Med Chem'}, { 'key': '6770_CR70', 'doi-asserted-by': 'crossref', 'unstructured': 'Johnson TO, Adegboyega AE, Iwaloye O, Eseola OA, Plass W, Afolabi B, ' 'Rotimi D, Ahmed EI, Albrakati A, Batiha GE, Adeyemi OS (2021) ' 'Computational study of the therapeutic potentials of a new series of ' 'imidazole derivatives against SARS-CoV-2. J Pharmacol Sci', 'DOI': '10.1016/j.jphs.2021.05.004'}, { 'issue': '2', 'key': '6770_CR71', 'doi-asserted-by': 'publisher', 'first-page': '416', 'DOI': '10.1016/j.bbrc.2017.01.140', 'volume': '484', 'author': 'L Chen', 'year': '2017', 'unstructured': 'Chen L, Wang L, Shen H, Lin H, Li D (2017) Anthelminthic drug ' 'niclosamide sensitizes the responsiveness of cervical cancer cells to ' 'paclitaxel via oxidative stress-mediated mTOR inhibition. Biochem ' 'Biophys Res Commun 484(2):416–421', 'journal-title': 'Biochem Biophys Res Commun'}, { 'issue': '6', 'key': '6770_CR72', 'doi-asserted-by': 'publisher', 'first-page': 'e04050', 'DOI': '10.1016/j.heliyon.2020.e04050', 'volume': '6', 'author': 'N Niyomdecha', 'year': '2020', 'unstructured': 'Niyomdecha N, Suptawiwat O, Boonarkart C, Jitobaom K, Auewarakul P ' '(2020) Inhibition of human immunodeficiency virus type 1 by niclosamide ' 'through mTORC1 inhibition. Heliyon 6(6):e04050', 'journal-title': 'Heliyon'}, { 'issue': '5', 'key': '6770_CR73', 'doi-asserted-by': 'publisher', 'first-page': '319', 'DOI': '10.1038/s41577-021-00536-9', 'volume': '21', 'author': 'A Bonaventura', 'year': '2021', 'unstructured': 'Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, ' 'Dentali F, Montecucco F, Massberg S, Levi M, Abbate A (2021) Endothelial ' 'dysfunction and immunothrombosis as key pathogenic mechanisms in ' 'COVID-19. Nat Rev Immunol 21(5):319–329', 'journal-title': 'Nat Rev Immunol'}, { 'key': '6770_CR74', 'first-page': '1', 'volume': '27', 'author': 'S Engin', 'year': '2021', 'unstructured': 'Engin S, Yasar YK, Barut EN, Sezen SF (2021) Improved ' 'endothelium-dependent relaxation of thoracic aorta in ' 'niclosamide-treated diabetic rats. Cardiovasc Toxicol 27:1–9', 'journal-title': 'Cardiovasc Toxicol'}, { 'key': '6770_CR75', 'unstructured': 'Laubscher GJ, Lourens PJ, Venter C, Grobbelaar LM, Kell DB, Pretorius E ' '(2021) A decision-tree approach to treat platelet hyperactivity and ' 'anomalous blood clotting in acute COVID-19 patients. medRxiv'}, { 'key': '6770_CR76', 'first-page': '142', 'volume': '2', 'author': 'G Hamilton', 'year': '2017', 'unstructured': 'Hamilton G, Rath B (2017) Repurposing of anthelminthics as anticancer ' 'drugs. Oncomedicine 2:142–149', 'journal-title': 'Oncomedicine'}, { 'issue': '4', 'key': '6770_CR77', 'doi-asserted-by': 'publisher', 'first-page': '384', 'DOI': '10.1002/cbin.10915', 'volume': '42', 'author': 'R Ke', 'year': '2018', 'unstructured': 'Ke R, Xu Q, Li C, Luo L, Huang D (2018) Mechanisms of AMPK in the ' 'maintenance of ATP balance during energy metabolism. Cell Biol Int ' '42(4):384–392', 'journal-title': 'Cell Biol Int'}], 'container-title': 'Molecular Biology Reports', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11033-021-06770-7.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s11033-021-06770-7/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11033-021-06770-7.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 11, 11]], 'date-time': '2023-11-11T10:12:25Z', 'timestamp': 1699697545000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s11033-021-06770-7'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 10, 18]]}, 'references-count': 77, 'journal-issue': {'issue': '12', 'published-print': {'date-parts': [[2021, 12]]}}, 'alternative-id': ['6770'], 'URL': 'http://dx.doi.org/10.1007/s11033-021-06770-7', 'relation': {}, 'ISSN': ['0301-4851', '1573-4978'], 'subject': [], 'container-title-short': 'Mol Biol Rep', 'published': {'date-parts': [[2021, 10, 18]]}, 'assertion': [ { 'value': '10 June 2021', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '17 August 2021', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '18 October 2021', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The authors declare that they have no competing interests.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of interest'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}